Andere talen Laurus Labs Limited Bombay S.E.

Aandelen

LAURUSLABS

INE947Q01028

Vertraagde tijd Bombay S.E. Andere beurzen 12:00:49 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
433 ^INR	+0,67%		-2,22%	+0,66%

26/01	Laurus Labs, Sloveens Krka gaan JV vormen; Laurus-aandelen dalen 6%	MT
25/01	Laurus Labs Limited bereikt een overeenkomst met Krka om een joint venture bedrijf op te richten in Hyderabad, India, namelijk Krka Pharma Pvt. Ltd	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Laurus Labs Board to Consider Second Interim Dividend for Fiscal Year 2024	18/04
Laurus Labs Incorporates New JV Company with Slovenia-Based Pharmaceutical Company	15/04
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%	26/01
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd	25/01
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24/01
INDIA STOCKS-IT drives losses in Indian shares ahead of Fed policy outcome	13/12
Indian shares set to open higher; focus turns to Fed policy	13/12
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio	21/11
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.	20/11
Laurus Labs Limited Announces Resignation of Chandrakanth Chereddi as Non-Executive Director	20-10-23
Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023	20-10-23
Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20-10-23
Laurus Labs Limited agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million.	11-09-23
India's Divi's Labs Q1 profit slumps on drug pricing pressures	14-08-23
Laurus Labs' Consolidated Profit Tanks in Fiscal Q1; Shares Climb 4%	31-07-23
Laurus Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27-07-23
Laurus Labs Pays First Tranche to Acquire Additional Stake in Cell and Gene Therapy Company	13-07-23
CARE Affirms AA Rating on Laurus Labs' Long-term Bank Financing; Outlook Stable	27-06-23
Laurus Labs Ties Up with Indian Institute for Novel Gene Therapy Advancement in India	19-06-23
Laurus Labs Signs Memorandum of Agreement with IIT Kanpur for Novel Gene Therapy Assets	19-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Laurus Labs Limited Bombay S.E.

Aandelen

LAURUSLABS

INE947Q01028

Andere talen

Filters